These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23020553)

  • 1. Complex carriers of affibody-displaying bio-nanocapsules and composition-varied liposomes for HER2-expressing breast cancer cell-specific protein delivery.
    Nishimura Y; Ishii J; Okazaki F; Ogino C; Kondo A
    J Drug Target; 2012 Dec; 20(10):897-905. PubMed ID: 23020553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells.
    Shishido T; Mieda H; Hwang SY; Nishimura Y; Tanaka T; Ogino C; Fukuda H; Kondo A
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5726-31. PubMed ID: 20801029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials.
    Jung J; Matsuzaki T; Tatematsu K; Okajima T; Tanizawa K; Kuroda S
    J Control Release; 2008 Mar; 126(3):255-64. PubMed ID: 18207275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular trafficking of bio-nanocapsule-liposome complex: Identification of fusogenic activity in the pre-S1 region of hepatitis B virus surface antigen L protein.
    Somiya M; Sasaki Y; Matsuzaki T; Liu Q; Iijima M; Yoshimoto N; Niimi T; Maturana AD; Kuroda S
    J Control Release; 2015 Aug; 212():10-8. PubMed ID: 26074149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chapter 8 - Bio-nanocapsule-liposome conjugates for in vivo pinpoint drug and gene delivery.
    Kasuya T; Jung J; Kinoshita R; Goh Y; Matsuzaki T; Iijima M; Yoshimoto N; Tanizawa K; Kuroda S
    Methods Enzymol; 2009; 464():147-66. PubMed ID: 19903554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus envelope L protein-derived bio-nanocapsules: mechanisms of cellular attachment and entry into human hepatic cells.
    Yamada M; Oeda A; Jung J; Iijima M; Yoshimoto N; Niimi T; Jeong SY; Choi EK; Tanizawa K; Kuroda S
    J Control Release; 2012 Jun; 160(2):322-9. PubMed ID: 22100387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granting specificity for breast cancer cells using a hepatitis B core particle with a HER2-targeted affibody molecule.
    Nishimura Y; Mimura W; Mohamed Suffian IF; Amino T; Ishii J; Ogino C; Kondo A
    J Biochem; 2013 Mar; 153(3):251-6. PubMed ID: 23235317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered bio-nanocapsules, the selective vector for drug delivery system.
    Yu D; Fukuda T; Tuoya ; Kuroda S; Tanizawa K; Kondo A; Ueda M; Yamada T; Tada H; Seno M
    IUBMB Life; 2006 Jan; 58(1):1-6. PubMed ID: 16596748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affibody-displaying bio-nanocapsules effective in EGFR, typical biomarker, expressed in various cancer cells.
    Nishimura Y; Ezawa R; Ishii J; Ogino C; Kondo A
    Bioorg Med Chem Lett; 2017 Jan; 27(2):336-341. PubMed ID: 27908760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a macrophage-targeting and phagocytosis-inducing bio-nanocapsule-based nanocarrier for drug delivery.
    Li H; Tatematsu K; Somiya M; Iijima M; Kuroda S
    Acta Biomater; 2018 Jun; 73():412-423. PubMed ID: 29673839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiae.
    Jung J; Iijima M; Yoshimoto N; Sasaki M; Niimi T; Tatematsu K; Jeong SY; Choi EK; Tanizawa K; Kuroda S
    Protein Expr Purif; 2011 Aug; 78(2):149-55. PubMed ID: 21515381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting cancer cell-specific RNA interference by siRNA delivery using a complex carrier of affibody-displaying bio-nanocapsules and liposomes.
    Nishimura Y; Mieda H; Ishii J; Ogino C; Fujiwara T; Kondo A
    J Nanobiotechnology; 2013 Jun; 11():19. PubMed ID: 23800313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bio-nanocapsules for in vivo pinpoint drug delivery].
    Jung J; Kasuya T; Tanizawa K; Kuroda S
    Yakugaku Zasshi; 2007 May; 127(5):797-805. PubMed ID: 17473521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The specific delivery of proteins to human liver cells by engineered bio-nanocapsules.
    Yu D; Amano C; Fukuda T; Yamada T; Kuroda S; Tanizawa K; Kondo A; Ueda M; Yamada H; Tada H; Seno M
    FEBS J; 2005 Jul; 272(14):3651-60. PubMed ID: 16008564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific protein delivery to target cells by antibody-displaying bionanocapsules.
    Kurata N; Shishido T; Muraoka M; Tanaka T; Ogino C; Fukuda H; Kondo A
    J Biochem; 2008 Dec; 144(6):701-7. PubMed ID: 18838435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of polyplex to human hepatic cells by bio-nanocapsules, hepatitis B virus surface antigen L protein particles.
    Somiya M; Yoshimoto N; Iijima M; Niimi T; Dewa T; Jung J; Kuroda S
    Bioorg Med Chem; 2012 Jun; 20(12):3873-9. PubMed ID: 22591855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.
    Cheema SK; Gobin AS; Rhea R; Lopez-Berestein G; Newman RA; Mathur AB
    Int J Pharm; 2007 Aug; 341(1-2):221-9. PubMed ID: 17499461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bio-nanocapsules displaying various immunoglobulins as an active targeting-based drug delivery system.
    Tatematsu K; Iijima M; Yoshimoto N; Nakai T; Okajima T; Kuroda S
    Acta Biomater; 2016 Apr; 35():238-47. PubMed ID: 26876802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.
    Kirpotin DB; Drummond DC; Shao Y; Shalaby MR; Hong K; Nielsen UB; Marks JD; Benz CC; Park JW
    Cancer Res; 2006 Jul; 66(13):6732-40. PubMed ID: 16818648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
    Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.